INVIRAGEN, INC. — Form D/A
INVIRAGEN, INC. of FORT COLLINS, CO, a company, filed a Form D amendment with the SEC on 2012-01-24. The offering totals $15.3M, of which $15.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-01-24
- Form: D/A
- Accession: 0001461681-12-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $15.3M
- Amount sold: $15.3M
- Investors: 24
- Date of first sale: 2009-09-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-134986
Issuer
- Name: INVIRAGEN, INC.
- CIK: 0001461681
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2006
- Address: 1613 PROSPECT PARKWAY, FORT COLLINS, CO, 80525
- Phone: 970-672-4918
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| HENG TONG CHOO | Director | RAFFLES CITY TOWER, U0 |
| JOHN TONG NEIS | Director | MADISON, WI |
| FRED TONG SCHWARZER | Director | PALO ALTO, CA |
| DAN STINCHCOMB | Director | FORT COLLINS, CO |
| JORGE OSORIO | Executive Officer | FORT COLLINS, CO |
| DAN STINCHCOMB | Executive Officer | FORT COLLINS, CO |
| JORGE OSORIO | Promoter | FORT COLLINS, CO |
| DAN STINCHCOMB | Promoter | FORT COLLINS, CO |
| JERRY TONG SADOFF | Director | FORT COLLINS, CO |
| REX R O'NEAL | Executive Officer | BOULDER, CO |
Other filings by this issuer (3)
More